Clinica Baviera (CBAV) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.146x

Based on the latest financial reports, Clinica Baviera (CBAV) has a cash flow conversion efficiency ratio of 0.146x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.17 Million ≈ $16.57 Million USD) by net assets (€97.36 Million ≈ $113.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Clinica Baviera - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Clinica Baviera's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Clinica Baviera total liabilities for a breakdown of total debt and financial obligations.

Clinica Baviera Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinica Baviera ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
China Railway Signal & Communication Corporation Limited F:RS3	0.009x
New Mountain Finance Corporation NASDAQ:NMFC	0.018x
Macmic Science & Technology Co Ltd SHG:688711	0.040x
Close Brothers Group plc F:CS3	-0.081x
YoungPoong KO:000670	0.000x
EnTie Commercial Bank Ltd TW:2849	-0.001x
Radius Recycling, Inc. NASDAQ:RDUS	0.006x
ENEFIT GREEN AS F:I6B	0.056x

Annual Cash Flow Conversion Efficiency for Clinica Baviera (2005–2024)

The table below shows the annual cash flow conversion efficiency of Clinica Baviera from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see CBAV stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€98.36 Million ≈ $114.99 Million	€62.76 Million ≈ $73.38 Million	0.638x	+1.85%
2023-12-31	€92.28 Million ≈ $107.88 Million	€57.81 Million ≈ $67.59 Million	0.627x	-19.75%
2022-12-31	€68.37 Million ≈ $79.93 Million	€53.38 Million ≈ $62.40 Million	0.781x	-7.70%
2021-12-31	€55.39 Million ≈ $64.76 Million	€46.86 Million ≈ $54.78 Million	0.846x	+20.75%
2020-12-31	€44.90 Million ≈ $52.50 Million	€31.46 Million ≈ $36.77 Million	0.700x	-15.05%
2019-12-31	€30.80 Million ≈ $36.01 Million	€25.40 Million ≈ $29.70 Million	0.825x	+41.07%
2018-12-31	€28.76 Million ≈ $33.63 Million	€16.81 Million ≈ $19.66 Million	0.585x	-8.14%
2017-12-31	€24.88 Million ≈ $29.09 Million	€15.83 Million ≈ $18.51 Million	0.636x	-12.74%
2016-12-31	€18.57 Million ≈ $21.72 Million	€13.55 Million ≈ $15.84 Million	0.729x	+43.39%
2015-12-31	€21.31 Million ≈ $24.92 Million	€10.84 Million ≈ $12.67 Million	0.509x	+6.31%
2014-12-31	€20.20 Million ≈ $23.62 Million	€9.66 Million ≈ $11.30 Million	0.478x	+18.62%
2013-12-31	€25.35 Million ≈ $29.63 Million	€10.22 Million ≈ $11.95 Million	0.403x	+4.02%
2012-12-31	€20.86 Million ≈ $24.38 Million	€8.09 Million ≈ $9.45 Million	0.388x	-36.41%
2011-12-31	€23.83 Million ≈ $27.86 Million	€14.53 Million ≈ $16.98 Million	0.610x	-5.44%
2010-12-31	€22.40 Million ≈ $26.19 Million	€14.45 Million ≈ $16.89 Million	0.645x	+65.96%
2009-12-31	€20.87 Million ≈ $24.39 Million	€8.11 Million ≈ $9.48 Million	0.388x	-27.99%
2008-12-31	€19.02 Million ≈ $22.24 Million	€10.26 Million ≈ $12.00 Million	0.539x	-45.12%
2007-12-31	€19.88 Million ≈ $23.24 Million	€19.54 Million ≈ $22.84 Million	0.983x	+21.61%
2006-12-31	€19.49 Million ≈ $22.79 Million	€15.75 Million ≈ $18.42 Million	0.808x	-11.07%
2005-12-31	€14.34 Million ≈ $16.76 Million	€13.03 Million ≈ $15.23 Million	0.909x	--

About Clinica Baviera

MC:CBAV Spain Diagnostics & Research

Market Cap

$1.05 Billion

€896.80 Million EUR

Market Cap Rank

#9904 Global

#69 in Spain

Share Price

€56.00

Change (1 day)

+0.36%

52-Week Range

€37.00 - €56.00

All Time High

€56.00